EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Q32 Bio Inc.
QTTB

QTTB Q32 Bio Inc.

Q32 Bio Inc. · NASDAQ
Market Closed
10.54
▼ ⁦-2.95%⁩ (-0.32)
Market Cap$313.7M
Beta-0.33
52w Low52w High
1.6223.57
Last Week
⁦-1.68%⁩
Last Month
⁦-30.43%⁩
Last 3 Months
⁦-24.71%⁩
Last Year
⁦+516.37%⁩
EL7 Factor Analysis
How we score this
Overall99
Excellent — top fifth of the marketSuper StockF 3/8Better than 99% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
75
4.4x▲17.6xTop tier
▸
Growth
76
—7.1%Top tier
▸
Quality
99
34.8%▲4.5%Top tier
▸
Safety
90
—2.6xTop tier
▸
Capital Return
88
—2.15%Top tier
▸
Momentum
80
786.0%▲2.3%Top tier
▸
Sentiment
44
5▲3Around median

Frequently Asked Questions

What is Q32 Bio Inc. stock?▼

Q32 Bio Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Q32 Bio Inc.?▼

You can buy Q32 Bio Inc. shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Q32 Bio Inc.?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Q32 Bio Inc. pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Q32 Bio Inc.?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

Fair Value
Low confidenceCurrent price$11
Analyst target · 2 analysts
$36
—
Range ⁦$14–$66⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener

AI analysis from the earnings call, financials and news

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 2 analysts setting price target
$38.00
⁦+260.5%⁩
Current Price $10.54·Median $36.00
Low
$14.00
High
$66.00
Current price
$10.54
Average target
$38.00
Street summary

Stable Targets Amid High Dispersion

The consensus price target remained stable at 38 versus 38 one day and seven days ago, with the number of analysts remaining at two. Over 30 days, the consensus declined from 39 to 38, a decrease of 1 or 2.56%, while the target range remained wide between 14 and 66, with the median at 36; this reflects significant dispersion in estimates despite the limited number of analysts.

As of 2026-09-16
Revisions momentum · 30d
⁦-2.6%⁩
Average rating
★ 4.17
Buy
Analyst coverage
6
Buy conviction
100%
High
Rating activity · 30d
0↑ · 0↓
Target dispersion
493%
Wide
Analyst ratings over time6 analysts rating
1
5
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.67 → 4.17
Recent analyst moves
  • = Reiterate2026-09-16
    Cantor Fitzgerald
    Overweight
  • = Reiterate2026-08-24
    Morgan Stanley
    Overweight
  • = Reiterate2026-07-28
    H.C. Wainwright
    Buy
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    4.40x
    3.85x44.95x
    Very cheap
  • Forward P/E
    —
    —
  • EV / EBITDA
    2.38x
    3.78x30.25x
    Very cheap
  • FCF Yield
    -13.3%
    -139.6%7.8%
    Strong
  • Revenue Growth YoY
    —
    —
  • EPS Growth YoY
    711.8%
    -159.3%129.8%
    Exceptional
  • Gross Margin
    —
    —
  • ROIC
    34.8%
    -154.2%16.1%
    Exceptional
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    —
    —
Financial Analysis
|